ArticleBMC nephrology2025
Nonlinear association between serum iron levels and moderate-to-severe uremic pruritus in peritoneal dialysis patients: a cross-sectional study.
Article in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the occurrence of uremic pruritus among peritoneal dialysis (PD) patients and explore its correlation with serum iron levels.
methodsA cross-sectional study was carried out on 189 PD patients at a single center in China. The severity of pruritus was assessed through the validated 5-D Itch Scale questionnaire. The relationship between clinical factors and pruritus was examined using multivariate logistic regression, restricted cubic spline analysis, piecewise regression, and cluster analysis of iron metabolism patterns.
resultsModerate/severe pruritus affected 27.5% of participants, mainly on lower limbs (52.9%) and back (46.6%). Serum iron was significantly higher in the moderate/severe pruritus group (18.43 ± 8.50 vs. 15.84 ± 6.09 µmol/L, p = 0.029). After adjustments, each standard deviation increase in serum iron corresponded to higher odds of moderate/severe pruritus (odds ratio (OR) = 1.45, 95% confidence interval (CI):1.03–2.08, p = 0.037). Analysis revealed a threshold association(p = 0.043) with an inflection point at 13.7µmol/L, above which each unit increase in serum iron raised pruritus odds by 10% (OR = 1.10, 95%CI:1.03–1.18, p = 0.006). Cluster analysis identified that patients with high transferrin saturation (TSAT), moderate ferritin, and high serum iron had the highest pruritus prevalence (52.8%).
conclusionIn PD patients, we identified a threshold effect of serum iron on uremic pruritus. Iron levels above 13.7 µmol/L independently worsened pruritus, especially in patients with high TSAT, moderate ferritin, and high serum iron, where prevalence reached 52.8%. These findings highlight the importance of assessing iron status and personalized management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.